Berberine, a natural lipid-lowering drug, exerts prothrombotic effects on vascular cells (Q34600461)

3 August 2017

Berberine, a natural lipid-lowering drug, exerts prothrombotic effects on vascular cells (English)

1 reference

3 August 2017

3

Thomas F Lüscher

1 reference

3 August 2017

Erik W Holy

1

1 reference

PubMed ID

19014947

3 August 2017

Alexander Akhmedov

series ordinal

2

1 reference

PubMed ID

19014947

3 August 2017

Felix C Tanner

series ordinal

4

1 reference

3 August 2017

30 October 2008

1 reference

Journal of Molecular and Cellular Cardiology

3 August 2017

1 reference

3 August 2017

46

1 reference

3 August 2017

2

1 reference

3 August 2017

234-240

1 reference

Tissue factor in cardiovascular diseases: molecular mechanisms and clinical implications

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.011

Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.011

Celecoxib decreases endothelial tissue factor expression through inhibition of c-Jun terminal NH2 kinase phosphorylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.011

Histamine induces tissue factor expression: implications for acute coronary syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.011

Dexamethasone enhances LPS induction of tissue factor expression in human monocytic cells by increasing tissue factor mRNA stability.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.011

Tissue factor modulates the thrombogenicity of human atherosclerotic plaques.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.011

Rapamycin, but not FK-506, increases endothelial tissue factor expression: implications for drug-eluting stent design

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.011

Paclitaxel enhances thrombin-induced endothelial tissue factor expression via c-Jun terminal NH2 kinase activation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.011

The haemostatic role of tissue factor pathway inhibitor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.011

A balance between tissue factor and tissue factor pathway inhibitor is required for embryonic development and hemostasis in adult mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.011

Local inhibition of tissue factor reduces the thrombogenicity of disrupted human atherosclerotic plaques: effects of tissue factor pathway inhibitor on plaque thrombogenicity under flow conditions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.011

Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.011

Extracellular signal-regulated kinase-dependent stabilization of hepatic low-density lipoprotein receptor mRNA by herbal medicine berberine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.011

Simvastatin blunts endotoxin-induced tissue factor in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.011

Statin prevents tissue factor expression in human endothelial cells: role of Rho/Rho-kinase and Akt pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.011

Endothelial cell expression of tissue factor in sickle mice is augmented by hypoxia/reoxygenation and inhibited by lovastatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.011

Inflammation in atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.011

Cocaine unbalances endothelial tissue factor and tissue factor pathway inhibitor expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.011

Tissue factor mRNA in THP-1 monocytic cells is regulated at both transcriptional and posttranscriptional levels in response to lipopolysaccharide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.011

Regulation of mRNA stability in mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.011

The highways and byways of mRNA decay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.011

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.011

Statins do more than just lower cholesterol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.011

Statins prevent NF-kappaB transactivation independently of the IKK-pathway in human endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.10.011

10.1016/J.YJMCC.2008.10.011

7 January 2021

Identifiers

DOI

1 reference

3 August 2017

1 reference

PubMed ID

19014947